country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-P11826

Copy Link Print Information

T2 peptide-1

T2 peptide-1 is a linear peptide derived from Lumican degradation. T2 peptide-1 exhibits activity against endometrial adhesion progression and ability to inhibit the Lumican−Collagen I interaction. T2 peptide-1 can be used for the research of liver fibrosis.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Formule: C₆₆H₁₀₃N₁₇O₂₅
Masse moléculaire:1534.62

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Synthèse personnalisée de peptides

T2 peptide-1 Chemical Structure

Size

Prix

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

IC₅₀ & Target^[1]

Collagen I

In Vitro

T2 peptide-1 (10 μM; 1 h) inhibits the Lumican-Collagen I interaction by 12.66^[1].
T2 peptide-1 (10 μM; 24 h) reduces TGF-β1-induced Collagen I expression in human LX2 hepatic stellate cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

human LX2 hepatic stellate cells (TGF-β1-stimulated)
Concentration:

10 μM
Incubation Time:

24 h
Result:

Reduced TGF-β1-induced COL1A1 protein levels in LX2 cells to a relative level of ~8 (normalized to GAPDH), which was lower than the TGF-β1-only group (relative level ~10).

In Vivo

T2 peptide-1 (1.0 mg/kg; i.p.; single dose) exhibits rapid elimination following intraperitoneal administration in Sprague-Dawley rats^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Sprague-Dawley (male)^[1]
Dosage:

1.0 mg/kg
Administration:

i.p.; single dose
Result:

Exhibited rapid elimination from circulation.

Chemical Information

Masse moléculaire 1534.62
Formule C₆₆H₁₀₃N₁₇O₂₅
Sequence

Tyr-Leu-Asp-Asn-Asn-Lys-Ile-Ser-Asn-Ile-Pro-Asp-Glu
Sequence Shortening

YLDNNKISNIPDE
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Instruction de manipulation (2659 KB)

Références

[1]. Wei X, et al. Structure-Based Development of a Novel Macrocyclic Peptide to Disrupt the Lumican-Collagen I Interaction in Liver Fibrosis. J Med Chem. 2025;68(23):25523-25538. [Content Brief]

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

Obtenir un devis En stock